People with Sjögren’s disease who received the experimental therapy ianalumab (VAY736) in Phase 3 clinical trials reported greater reductions…
Articles by Marisa Wexler, MS
An experimental therapy from Ouro Medicines is being tested in a Phase 1b clinical trial on people who have…
A machine learning tool that can analyze certain molecules in stool samples may help to better diagnose primary Sjögren’s…
Primary Sjögren’s disease-associated interstitial lung disease (pSjD-ILD) — a form of Sjögren’s disease that’s characterized by scarring in the…
A traditional Chinese medicine formulation called Qihuang Jianpi ZiShen Granule (QJZG) may help to alleviate Sjögren’s disease by…
Using artificial intelligence (AI) to analyze biopsies of the salivary glands in people with Sjögren’s disease may help identify…
Efgartigimod is entering a Phase 3 clinical trial after data from a proof-of-concept Phase 2 trial showed it outperformed a…
A study found significant associations between eye surface changes and alterations in immune activity throughout the body in people with primary…
Cullinan Therapeutics is planning the launch of a clinical trial in the U.S. to test its treatment candidate CLN-978…
Immunovant is planning to launch a potentially registrational clinical trial this summer to test its treatment candidate IMVT-1402 in…